<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Sovari, Sara Nasiri</dc:creator>
  <dc:creator>Vojnovic, Sandra</dc:creator>
  <dc:creator>Bogojevic, Sanja Skaro</dc:creator>
  <dc:creator>Crochet, Aurélien</dc:creator>
  <dc:creator>Pavic, Aleksandar</dc:creator>
  <dc:creator>Nikodinovic-Runic, Jasmina</dc:creator>
  <dc:creator>Zobi, Fabio</dc:creator>
  <dc:date>2020-11-01</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">We have prepared a series of ten 3-arylcoumarin molecules, their respective fac-  [Re(CO)3(bpy)L]+ and fac-[Re(CO)3(L⁀L)Br] complexes and tested all compounds  for their antimicrobial efficacy. Whereas the 3-arylcoumarin ligands are virtually  inactive against the human-associated pathogens with minimum inhibitory  concentrations (MICs) &gt; 150 μM, when coordinated to the fac-[Re(CO)3]+ core, most  of the resulting complexes showed remarkable antibacterial potency. Several rhenium  complexes exhibit activity in nanomolar concentrations against Gram-positive  pathogens such as Staphylococcus aureus strains, including methicillin-resistant S.  aureus (MRSA) and Enterococcus faecium. The molecules do not affect bacterial cell  membrane potential, but some of the most potent complexes strongly interact with  DNA, indicating it as a possible target for their mode of action. In vivo studies in the  zebrafish model showed that the complexes with anti-staphylococcal/MRSA activity  were non-toxic to the organism even at much higher doses of the corresponding  MICs. In the zebrafish-MRSA infection model, the complexes increased the survival  rate of infected fish up to 100% and markedly reduced bacterial burden. Moreover, all  rescued fish developed normally following the treatments with the metallic  compounds.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/308825</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308825/files/zob_dsv.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/308825/files/zob_dsv_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejmech.2020.112533</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>European Journal of Medicinal Chemistry. - 2020, vol. 205, p. 112533</dc:source>
  <dc:subject>info:eu-repo/classification/udc/54</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
